Global mRNA Platform Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global mRNA Platform market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global mRNA Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global mRNA Platform market size and forecasts, in consumption value ($ Million), 2018-2029
Global mRNA Platform market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global mRNA Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global mRNA Platform market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Platform
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Platform market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac and Etherna, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
mRNA Platform market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe mRNA Platform product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Platform, with revenue, gross margin and global market share of mRNA Platform from 2018 to 2023.
Chapter 3, the mRNA Platform competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and mRNA Platform market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Platform.
Chapter 13, to describe mRNA Platform research findings and conclusion.
This report is a detailed and comprehensive analysis for global mRNA Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global mRNA Platform market size and forecasts, in consumption value ($ Million), 2018-2029
Global mRNA Platform market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global mRNA Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global mRNA Platform market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Platform
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Platform market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac and Etherna, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
mRNA Platform market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Infectious Disease Vaccines
- Cancer Vaccines
- Infectious Disease
- Cancer
- Arcturus Therapeutic
- Argos Therapeutics
- BioNTec
- CureVac
- Etherna
- Ethris
- GlaxoSmithKline
- Pfizer
- Translate Bio
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe mRNA Platform product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Platform, with revenue, gross margin and global market share of mRNA Platform from 2018 to 2023.
Chapter 3, the mRNA Platform competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and mRNA Platform market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Platform.
Chapter 13, to describe mRNA Platform research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of mRNA Platform
1.2 Market Estimation Caveats and Base Year
1.3 Classification of mRNA Platform by Type
1.3.1 Overview: Global mRNA Platform Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global mRNA Platform Consumption Value Market Share by Type in 2022
1.3.3 Infectious Disease Vaccines
1.3.4 Cancer Vaccines
1.4 Global mRNA Platform Market by Application
1.4.1 Overview: Global mRNA Platform Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Infectious Disease
1.4.3 Cancer
1.5 Global mRNA Platform Market Size & Forecast
1.6 Global mRNA Platform Market Size and Forecast by Region
1.6.1 Global mRNA Platform Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global mRNA Platform Market Size by Region, (2018-2029)
1.6.3 North America mRNA Platform Market Size and Prospect (2018-2029)
1.6.4 Europe mRNA Platform Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific mRNA Platform Market Size and Prospect (2018-2029)
1.6.6 South America mRNA Platform Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa mRNA Platform Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Arcturus Therapeutic
2.1.1 Arcturus Therapeutic Details
2.1.2 Arcturus Therapeutic Major Business
2.1.3 Arcturus Therapeutic mRNA Platform Product and Solutions
2.1.4 Arcturus Therapeutic mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Arcturus Therapeutic Recent Developments and Future Plans
2.2 Argos Therapeutics
2.2.1 Argos Therapeutics Details
2.2.2 Argos Therapeutics Major Business
2.2.3 Argos Therapeutics mRNA Platform Product and Solutions
2.2.4 Argos Therapeutics mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Argos Therapeutics Recent Developments and Future Plans
2.3 BioNTec
2.3.1 BioNTec Details
2.3.2 BioNTec Major Business
2.3.3 BioNTec mRNA Platform Product and Solutions
2.3.4 BioNTec mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BioNTec Recent Developments and Future Plans
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business
2.4.3 CureVac mRNA Platform Product and Solutions
2.4.4 CureVac mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 CureVac Recent Developments and Future Plans
2.5 Etherna
2.5.1 Etherna Details
2.5.2 Etherna Major Business
2.5.3 Etherna mRNA Platform Product and Solutions
2.5.4 Etherna mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Etherna Recent Developments and Future Plans
2.6 Ethris
2.6.1 Ethris Details
2.6.2 Ethris Major Business
2.6.3 Ethris mRNA Platform Product and Solutions
2.6.4 Ethris mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ethris Recent Developments and Future Plans
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline mRNA Platform Product and Solutions
2.7.4 GlaxoSmithKline mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GlaxoSmithKline Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer mRNA Platform Product and Solutions
2.8.4 Pfizer mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Translate Bio
2.9.1 Translate Bio Details
2.9.2 Translate Bio Major Business
2.9.3 Translate Bio mRNA Platform Product and Solutions
2.9.4 Translate Bio mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Translate Bio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global mRNA Platform Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of mRNA Platform by Company Revenue
3.2.2 Top 3 mRNA Platform Players Market Share in 2022
3.2.3 Top 6 mRNA Platform Players Market Share in 2022
3.3 mRNA Platform Market: Overall Company Footprint Analysis
3.3.1 mRNA Platform Market: Region Footprint
3.3.2 mRNA Platform Market: Company Product Type Footprint
3.3.3 mRNA Platform Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global mRNA Platform Consumption Value and Market Share by Type (2018-2023)
4.2 Global mRNA Platform Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global mRNA Platform Consumption Value Market Share by Application (2018-2023)
5.2 Global mRNA Platform Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America mRNA Platform Consumption Value by Type (2018-2029)
6.2 North America mRNA Platform Consumption Value by Application (2018-2029)
6.3 North America mRNA Platform Market Size by Country
6.3.1 North America mRNA Platform Consumption Value by Country (2018-2029)
6.3.2 United States mRNA Platform Market Size and Forecast (2018-2029)
6.3.3 Canada mRNA Platform Market Size and Forecast (2018-2029)
6.3.4 Mexico mRNA Platform Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe mRNA Platform Consumption Value by Type (2018-2029)
7.2 Europe mRNA Platform Consumption Value by Application (2018-2029)
7.3 Europe mRNA Platform Market Size by Country
7.3.1 Europe mRNA Platform Consumption Value by Country (2018-2029)
7.3.2 Germany mRNA Platform Market Size and Forecast (2018-2029)
7.3.3 France mRNA Platform Market Size and Forecast (2018-2029)
7.3.4 United Kingdom mRNA Platform Market Size and Forecast (2018-2029)
7.3.5 Russia mRNA Platform Market Size and Forecast (2018-2029)
7.3.6 Italy mRNA Platform Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific mRNA Platform Consumption Value by Type (2018-2029)
8.2 Asia-Pacific mRNA Platform Consumption Value by Application (2018-2029)
8.3 Asia-Pacific mRNA Platform Market Size by Region
8.3.1 Asia-Pacific mRNA Platform Consumption Value by Region (2018-2029)
8.3.2 China mRNA Platform Market Size and Forecast (2018-2029)
8.3.3 Japan mRNA Platform Market Size and Forecast (2018-2029)
8.3.4 South Korea mRNA Platform Market Size and Forecast (2018-2029)
8.3.5 India mRNA Platform Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia mRNA Platform Market Size and Forecast (2018-2029)
8.3.7 Australia mRNA Platform Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America mRNA Platform Consumption Value by Type (2018-2029)
9.2 South America mRNA Platform Consumption Value by Application (2018-2029)
9.3 South America mRNA Platform Market Size by Country
9.3.1 South America mRNA Platform Consumption Value by Country (2018-2029)
9.3.2 Brazil mRNA Platform Market Size and Forecast (2018-2029)
9.3.3 Argentina mRNA Platform Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa mRNA Platform Consumption Value by Type (2018-2029)
10.2 Middle East & Africa mRNA Platform Consumption Value by Application (2018-2029)
10.3 Middle East & Africa mRNA Platform Market Size by Country
10.3.1 Middle East & Africa mRNA Platform Consumption Value by Country (2018-2029)
10.3.2 Turkey mRNA Platform Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia mRNA Platform Market Size and Forecast (2018-2029)
10.3.4 UAE mRNA Platform Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 mRNA Platform Market Drivers
11.2 mRNA Platform Market Restraints
11.3 mRNA Platform Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 mRNA Platform Industry Chain
12.2 mRNA Platform Upstream Analysis
12.3 mRNA Platform Midstream Analysis
12.4 mRNA Platform Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of mRNA Platform
1.2 Market Estimation Caveats and Base Year
1.3 Classification of mRNA Platform by Type
1.3.1 Overview: Global mRNA Platform Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global mRNA Platform Consumption Value Market Share by Type in 2022
1.3.3 Infectious Disease Vaccines
1.3.4 Cancer Vaccines
1.4 Global mRNA Platform Market by Application
1.4.1 Overview: Global mRNA Platform Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Infectious Disease
1.4.3 Cancer
1.5 Global mRNA Platform Market Size & Forecast
1.6 Global mRNA Platform Market Size and Forecast by Region
1.6.1 Global mRNA Platform Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global mRNA Platform Market Size by Region, (2018-2029)
1.6.3 North America mRNA Platform Market Size and Prospect (2018-2029)
1.6.4 Europe mRNA Platform Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific mRNA Platform Market Size and Prospect (2018-2029)
1.6.6 South America mRNA Platform Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa mRNA Platform Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Arcturus Therapeutic
2.1.1 Arcturus Therapeutic Details
2.1.2 Arcturus Therapeutic Major Business
2.1.3 Arcturus Therapeutic mRNA Platform Product and Solutions
2.1.4 Arcturus Therapeutic mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Arcturus Therapeutic Recent Developments and Future Plans
2.2 Argos Therapeutics
2.2.1 Argos Therapeutics Details
2.2.2 Argos Therapeutics Major Business
2.2.3 Argos Therapeutics mRNA Platform Product and Solutions
2.2.4 Argos Therapeutics mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Argos Therapeutics Recent Developments and Future Plans
2.3 BioNTec
2.3.1 BioNTec Details
2.3.2 BioNTec Major Business
2.3.3 BioNTec mRNA Platform Product and Solutions
2.3.4 BioNTec mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BioNTec Recent Developments and Future Plans
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business
2.4.3 CureVac mRNA Platform Product and Solutions
2.4.4 CureVac mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 CureVac Recent Developments and Future Plans
2.5 Etherna
2.5.1 Etherna Details
2.5.2 Etherna Major Business
2.5.3 Etherna mRNA Platform Product and Solutions
2.5.4 Etherna mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Etherna Recent Developments and Future Plans
2.6 Ethris
2.6.1 Ethris Details
2.6.2 Ethris Major Business
2.6.3 Ethris mRNA Platform Product and Solutions
2.6.4 Ethris mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ethris Recent Developments and Future Plans
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline mRNA Platform Product and Solutions
2.7.4 GlaxoSmithKline mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GlaxoSmithKline Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer mRNA Platform Product and Solutions
2.8.4 Pfizer mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Translate Bio
2.9.1 Translate Bio Details
2.9.2 Translate Bio Major Business
2.9.3 Translate Bio mRNA Platform Product and Solutions
2.9.4 Translate Bio mRNA Platform Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Translate Bio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global mRNA Platform Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of mRNA Platform by Company Revenue
3.2.2 Top 3 mRNA Platform Players Market Share in 2022
3.2.3 Top 6 mRNA Platform Players Market Share in 2022
3.3 mRNA Platform Market: Overall Company Footprint Analysis
3.3.1 mRNA Platform Market: Region Footprint
3.3.2 mRNA Platform Market: Company Product Type Footprint
3.3.3 mRNA Platform Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global mRNA Platform Consumption Value and Market Share by Type (2018-2023)
4.2 Global mRNA Platform Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global mRNA Platform Consumption Value Market Share by Application (2018-2023)
5.2 Global mRNA Platform Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America mRNA Platform Consumption Value by Type (2018-2029)
6.2 North America mRNA Platform Consumption Value by Application (2018-2029)
6.3 North America mRNA Platform Market Size by Country
6.3.1 North America mRNA Platform Consumption Value by Country (2018-2029)
6.3.2 United States mRNA Platform Market Size and Forecast (2018-2029)
6.3.3 Canada mRNA Platform Market Size and Forecast (2018-2029)
6.3.4 Mexico mRNA Platform Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe mRNA Platform Consumption Value by Type (2018-2029)
7.2 Europe mRNA Platform Consumption Value by Application (2018-2029)
7.3 Europe mRNA Platform Market Size by Country
7.3.1 Europe mRNA Platform Consumption Value by Country (2018-2029)
7.3.2 Germany mRNA Platform Market Size and Forecast (2018-2029)
7.3.3 France mRNA Platform Market Size and Forecast (2018-2029)
7.3.4 United Kingdom mRNA Platform Market Size and Forecast (2018-2029)
7.3.5 Russia mRNA Platform Market Size and Forecast (2018-2029)
7.3.6 Italy mRNA Platform Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific mRNA Platform Consumption Value by Type (2018-2029)
8.2 Asia-Pacific mRNA Platform Consumption Value by Application (2018-2029)
8.3 Asia-Pacific mRNA Platform Market Size by Region
8.3.1 Asia-Pacific mRNA Platform Consumption Value by Region (2018-2029)
8.3.2 China mRNA Platform Market Size and Forecast (2018-2029)
8.3.3 Japan mRNA Platform Market Size and Forecast (2018-2029)
8.3.4 South Korea mRNA Platform Market Size and Forecast (2018-2029)
8.3.5 India mRNA Platform Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia mRNA Platform Market Size and Forecast (2018-2029)
8.3.7 Australia mRNA Platform Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America mRNA Platform Consumption Value by Type (2018-2029)
9.2 South America mRNA Platform Consumption Value by Application (2018-2029)
9.3 South America mRNA Platform Market Size by Country
9.3.1 South America mRNA Platform Consumption Value by Country (2018-2029)
9.3.2 Brazil mRNA Platform Market Size and Forecast (2018-2029)
9.3.3 Argentina mRNA Platform Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa mRNA Platform Consumption Value by Type (2018-2029)
10.2 Middle East & Africa mRNA Platform Consumption Value by Application (2018-2029)
10.3 Middle East & Africa mRNA Platform Market Size by Country
10.3.1 Middle East & Africa mRNA Platform Consumption Value by Country (2018-2029)
10.3.2 Turkey mRNA Platform Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia mRNA Platform Market Size and Forecast (2018-2029)
10.3.4 UAE mRNA Platform Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 mRNA Platform Market Drivers
11.2 mRNA Platform Market Restraints
11.3 mRNA Platform Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 mRNA Platform Industry Chain
12.2 mRNA Platform Upstream Analysis
12.3 mRNA Platform Midstream Analysis
12.4 mRNA Platform Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global mRNA Platform Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA Platform Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global mRNA Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global mRNA Platform Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Arcturus Therapeutic Company Information, Head Office, and Major Competitors
Table 6. Arcturus Therapeutic Major Business
Table 7. Arcturus Therapeutic mRNA Platform Product and Solutions
Table 8. Arcturus Therapeutic mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Arcturus Therapeutic Recent Developments and Future Plans
Table 10. Argos Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Argos Therapeutics Major Business
Table 12. Argos Therapeutics mRNA Platform Product and Solutions
Table 13. Argos Therapeutics mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Argos Therapeutics Recent Developments and Future Plans
Table 15. BioNTec Company Information, Head Office, and Major Competitors
Table 16. BioNTec Major Business
Table 17. BioNTec mRNA Platform Product and Solutions
Table 18. BioNTec mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. BioNTec Recent Developments and Future Plans
Table 20. CureVac Company Information, Head Office, and Major Competitors
Table 21. CureVac Major Business
Table 22. CureVac mRNA Platform Product and Solutions
Table 23. CureVac mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. CureVac Recent Developments and Future Plans
Table 25. Etherna Company Information, Head Office, and Major Competitors
Table 26. Etherna Major Business
Table 27. Etherna mRNA Platform Product and Solutions
Table 28. Etherna mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Etherna Recent Developments and Future Plans
Table 30. Ethris Company Information, Head Office, and Major Competitors
Table 31. Ethris Major Business
Table 32. Ethris mRNA Platform Product and Solutions
Table 33. Ethris mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Ethris Recent Developments and Future Plans
Table 35. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline mRNA Platform Product and Solutions
Table 38. GlaxoSmithKline mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GlaxoSmithKline Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer mRNA Platform Product and Solutions
Table 43. Pfizer mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Translate Bio Company Information, Head Office, and Major Competitors
Table 46. Translate Bio Major Business
Table 47. Translate Bio mRNA Platform Product and Solutions
Table 48. Translate Bio mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Translate Bio Recent Developments and Future Plans
Table 50. Global mRNA Platform Revenue (USD Million) by Players (2018-2023)
Table 51. Global mRNA Platform Revenue Share by Players (2018-2023)
Table 52. Breakdown of mRNA Platform by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in mRNA Platform, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key mRNA Platform Players
Table 55. mRNA Platform Market: Company Product Type Footprint
Table 56. mRNA Platform Market: Company Product Application Footprint
Table 57. mRNA Platform New Market Entrants and Barriers to Market Entry
Table 58. mRNA Platform Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global mRNA Platform Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global mRNA Platform Consumption Value Share by Type (2018-2023)
Table 61. Global mRNA Platform Consumption Value Forecast by Type (2024-2029)
Table 62. Global mRNA Platform Consumption Value by Application (2018-2023)
Table 63. Global mRNA Platform Consumption Value Forecast by Application (2024-2029)
Table 64. North America mRNA Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America mRNA Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America mRNA Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America mRNA Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America mRNA Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America mRNA Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe mRNA Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe mRNA Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe mRNA Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe mRNA Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe mRNA Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe mRNA Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific mRNA Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific mRNA Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific mRNA Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific mRNA Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific mRNA Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific mRNA Platform Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America mRNA Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America mRNA Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America mRNA Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America mRNA Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America mRNA Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America mRNA Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa mRNA Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa mRNA Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa mRNA Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa mRNA Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa mRNA Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa mRNA Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 94. mRNA Platform Raw Material
Table 95. Key Suppliers of mRNA Platform Raw Materials
Table 1. Global mRNA Platform Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA Platform Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global mRNA Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global mRNA Platform Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Arcturus Therapeutic Company Information, Head Office, and Major Competitors
Table 6. Arcturus Therapeutic Major Business
Table 7. Arcturus Therapeutic mRNA Platform Product and Solutions
Table 8. Arcturus Therapeutic mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Arcturus Therapeutic Recent Developments and Future Plans
Table 10. Argos Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Argos Therapeutics Major Business
Table 12. Argos Therapeutics mRNA Platform Product and Solutions
Table 13. Argos Therapeutics mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Argos Therapeutics Recent Developments and Future Plans
Table 15. BioNTec Company Information, Head Office, and Major Competitors
Table 16. BioNTec Major Business
Table 17. BioNTec mRNA Platform Product and Solutions
Table 18. BioNTec mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. BioNTec Recent Developments and Future Plans
Table 20. CureVac Company Information, Head Office, and Major Competitors
Table 21. CureVac Major Business
Table 22. CureVac mRNA Platform Product and Solutions
Table 23. CureVac mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. CureVac Recent Developments and Future Plans
Table 25. Etherna Company Information, Head Office, and Major Competitors
Table 26. Etherna Major Business
Table 27. Etherna mRNA Platform Product and Solutions
Table 28. Etherna mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Etherna Recent Developments and Future Plans
Table 30. Ethris Company Information, Head Office, and Major Competitors
Table 31. Ethris Major Business
Table 32. Ethris mRNA Platform Product and Solutions
Table 33. Ethris mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Ethris Recent Developments and Future Plans
Table 35. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline mRNA Platform Product and Solutions
Table 38. GlaxoSmithKline mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GlaxoSmithKline Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer mRNA Platform Product and Solutions
Table 43. Pfizer mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Translate Bio Company Information, Head Office, and Major Competitors
Table 46. Translate Bio Major Business
Table 47. Translate Bio mRNA Platform Product and Solutions
Table 48. Translate Bio mRNA Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Translate Bio Recent Developments and Future Plans
Table 50. Global mRNA Platform Revenue (USD Million) by Players (2018-2023)
Table 51. Global mRNA Platform Revenue Share by Players (2018-2023)
Table 52. Breakdown of mRNA Platform by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in mRNA Platform, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key mRNA Platform Players
Table 55. mRNA Platform Market: Company Product Type Footprint
Table 56. mRNA Platform Market: Company Product Application Footprint
Table 57. mRNA Platform New Market Entrants and Barriers to Market Entry
Table 58. mRNA Platform Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global mRNA Platform Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global mRNA Platform Consumption Value Share by Type (2018-2023)
Table 61. Global mRNA Platform Consumption Value Forecast by Type (2024-2029)
Table 62. Global mRNA Platform Consumption Value by Application (2018-2023)
Table 63. Global mRNA Platform Consumption Value Forecast by Application (2024-2029)
Table 64. North America mRNA Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America mRNA Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America mRNA Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America mRNA Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America mRNA Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America mRNA Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe mRNA Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe mRNA Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe mRNA Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe mRNA Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe mRNA Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe mRNA Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific mRNA Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific mRNA Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific mRNA Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific mRNA Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific mRNA Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific mRNA Platform Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America mRNA Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America mRNA Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America mRNA Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America mRNA Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America mRNA Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America mRNA Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa mRNA Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa mRNA Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa mRNA Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa mRNA Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa mRNA Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa mRNA Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 94. mRNA Platform Raw Material
Table 95. Key Suppliers of mRNA Platform Raw Materials
LIST OF FIGURES
Figure 1. mRNA Platform Picture
Figure 2. Global mRNA Platform Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA Platform Consumption Value Market Share by Type in 2022
Figure 4. Infectious Disease Vaccines
Figure 5. Cancer Vaccines
Figure 6. Global mRNA Platform Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. mRNA Platform Consumption Value Market Share by Application in 2022
Figure 8. Infectious Disease Picture
Figure 9. Cancer Picture
Figure 10. Global mRNA Platform Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global mRNA Platform Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market mRNA Platform Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global mRNA Platform Consumption Value Market Share by Region (2018-2029)
Figure 14. Global mRNA Platform Consumption Value Market Share by Region in 2022
Figure 15. North America mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 18. South America mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 20. Global mRNA Platform Revenue Share by Players in 2022
Figure 21. mRNA Platform Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players mRNA Platform Market Share in 2022
Figure 23. Global Top 6 Players mRNA Platform Market Share in 2022
Figure 24. Global mRNA Platform Consumption Value Share by Type (2018-2023)
Figure 25. Global mRNA Platform Market Share Forecast by Type (2024-2029)
Figure 26. Global mRNA Platform Consumption Value Share by Application (2018-2023)
Figure 27. Global mRNA Platform Market Share Forecast by Application (2024-2029)
Figure 28. North America mRNA Platform Consumption Value Market Share by Type (2018-2029)
Figure 29. North America mRNA Platform Consumption Value Market Share by Application (2018-2029)
Figure 30. North America mRNA Platform Consumption Value Market Share by Country (2018-2029)
Figure 31. United States mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe mRNA Platform Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe mRNA Platform Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe mRNA Platform Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 38. France mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific mRNA Platform Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific mRNA Platform Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific mRNA Platform Consumption Value Market Share by Region (2018-2029)
Figure 45. China mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 48. India mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 51. South America mRNA Platform Consumption Value Market Share by Type (2018-2029)
Figure 52. South America mRNA Platform Consumption Value Market Share by Application (2018-2029)
Figure 53. South America mRNA Platform Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa mRNA Platform Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa mRNA Platform Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa mRNA Platform Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 62. mRNA Platform Market Drivers
Figure 63. mRNA Platform Market Restraints
Figure 64. mRNA Platform Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of mRNA Platform in 2022
Figure 67. Manufacturing Process Analysis of mRNA Platform
Figure 68. mRNA Platform Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. mRNA Platform Picture
Figure 2. Global mRNA Platform Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA Platform Consumption Value Market Share by Type in 2022
Figure 4. Infectious Disease Vaccines
Figure 5. Cancer Vaccines
Figure 6. Global mRNA Platform Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. mRNA Platform Consumption Value Market Share by Application in 2022
Figure 8. Infectious Disease Picture
Figure 9. Cancer Picture
Figure 10. Global mRNA Platform Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global mRNA Platform Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market mRNA Platform Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global mRNA Platform Consumption Value Market Share by Region (2018-2029)
Figure 14. Global mRNA Platform Consumption Value Market Share by Region in 2022
Figure 15. North America mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 18. South America mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 20. Global mRNA Platform Revenue Share by Players in 2022
Figure 21. mRNA Platform Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players mRNA Platform Market Share in 2022
Figure 23. Global Top 6 Players mRNA Platform Market Share in 2022
Figure 24. Global mRNA Platform Consumption Value Share by Type (2018-2023)
Figure 25. Global mRNA Platform Market Share Forecast by Type (2024-2029)
Figure 26. Global mRNA Platform Consumption Value Share by Application (2018-2023)
Figure 27. Global mRNA Platform Market Share Forecast by Application (2024-2029)
Figure 28. North America mRNA Platform Consumption Value Market Share by Type (2018-2029)
Figure 29. North America mRNA Platform Consumption Value Market Share by Application (2018-2029)
Figure 30. North America mRNA Platform Consumption Value Market Share by Country (2018-2029)
Figure 31. United States mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe mRNA Platform Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe mRNA Platform Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe mRNA Platform Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 38. France mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific mRNA Platform Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific mRNA Platform Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific mRNA Platform Consumption Value Market Share by Region (2018-2029)
Figure 45. China mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 48. India mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 51. South America mRNA Platform Consumption Value Market Share by Type (2018-2029)
Figure 52. South America mRNA Platform Consumption Value Market Share by Application (2018-2029)
Figure 53. South America mRNA Platform Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa mRNA Platform Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa mRNA Platform Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa mRNA Platform Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE mRNA Platform Consumption Value (2018-2029) & (USD Million)
Figure 62. mRNA Platform Market Drivers
Figure 63. mRNA Platform Market Restraints
Figure 64. mRNA Platform Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of mRNA Platform in 2022
Figure 67. Manufacturing Process Analysis of mRNA Platform
Figure 68. mRNA Platform Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
